Mickael Hiligsmann awarded ESCEO Medal of Excellence 2018

4 May 2018

Dr Mickael Hiligsmann, Assistant Professor in Health Economics and Health Technology Assessment at CAPHRI, was announced the winner of the ESCEO Medal of Excellence. The prestigious award honours an academic who has contributed significantly to the field of osteoporosis and musculoskeletal science through original and outstanding scientific contributions

Dr. Mickael Hiligsmann holds a PhD in Health, Medicine and Life Sciences from Maastricht University (2015), a PhD in Medical Sciences (2010), a master in Public Health (2006) and a master in Economics (2003) from the University of Liège. His main research interests include health technology assessment, cost-effectiveness analyses, valuation of health care (e.g. discretechoice experiments, best-worst scaling), patients involvement and medication adherence. He has been co-promotor of about 12 PhD students and is senior lecturer in health technology assessment and health economic courses at Maastricht University. Mickael has published about 140 scientific articles of which 60 have been conducted in the field of osteoporosis and osteoarthritis. He is a member of the scientific committees of IOF and ESCEO since several years, has (co-)chair several ESCEO-IOF working groups and is, among others, member of the editorial board of Osteoporosis International and Archives of Osteoporosis.

Dr Mickael Hiligsmann stated: “It is a great honor and privilege to receive this Award. I am extremely grateful to the hard work of so many excellent team members and collaborators who have contributed to these researches and this Award represent a wonderful recognition of the importance of economic evaluation and health technology assessment to optimize the treatment outcomes of our patients. We shall continue our efforts to help policy makers to efficiently allocate healthcare resources devoted to osteoporosis as well as to better understand how medication adherence and patient involvement in decision making could be improved in osteoporosis and other musculoskeletal conditions”.